Skip to main content

JANE STREET GROUP, LLC

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1595888 NEW YORK, NY

Position in RDY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,011,918
-$3,981,797 QoQ
Shares Held
276,875
-51.4% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 238 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Derivatives in RDY

reported options exposure · as of Mar 31, 2025
CallValue
$137,176
CallShares
10,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $557,642,679 across 56 Drug Manufacturers - Specialty & Generic names. RDY ranks #12 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RDY

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,011,918 276,875
2025-12-31 $7,993,715 569,353
2025-09-30 $16,502,759 1,180,455
2025-06-30 $15,020,138 999,344
2025-03-31 $137,176 10,400
2025-03-31 $23,414,083 1,775,139
2024-12-31 $24,453,861 1,548,693
2024-12-31 $164,216 10,400
2024-09-30 $15,269,415 192,189
2024-06-30 $22,232,927 291,809
2024-03-31 $8,300,872 113,168
2023-12-31 $342,681 4,925
2023-09-30 $456,989 6,834
2023-06-30 $13,280,426 210,433
2023-03-31 $282,031 4,954
2022-12-31 $290,317 5,610
2022-09-30 $831,368 15,884
2022-03-31 $286,062 5,133
2021-09-30 $390,840 6,000
2021-06-30 $232,953 3,169
2020-09-30 $433,845 6,237
2020-06-30 $212,358 4,006